DARE-19 Phase III Collaboration between AstraZeneca, Saint Luke’s Mid America Heart Institute and George Clinical Shows Treatment’s Well-Established Safety Profile Was Consistent in Patients with COVID-19

NEXT STORY
Onxeo Announces the Appointment of Dr. Shefali Agarwal as the Company’s Chairwoman of the Board
PREV STORY
Scipher Medicine Increases Patient Access for Prismra® by Expanding Intended Use in Autoimmune Patients
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

PreveCeutical Announces the Appointment of Dr. Harendra Parekh as Chief Research Officer

VANCOUVER, British Columbia, May 17, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (“PMI”) a ...

author_avatar
NASDAQ Market News

At 6.0% CAGR, Ultrasound Devices Market Expected to Grow USD 9.50 Bn by 2021

Sarasota, FL, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a ...

author_avatar
NASDAQ Market News

Molecular Templates, Inc. Reports Second Quarter 2018 Financial Results

AUSTIN, Texas, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq:MTEM, “Molecular” or “Molecular ...

author_avatar
NASDAQ Market News